lung cancer
Conditions
Interventions
Gold Standard:Pathological examination
image 
intelligent 
analysis 
technology, 
CT 
scanning
In 
hybridization
Detection 
of 
Shox2 
gene 
by 
Sponsors
Ruijin Hospital North, 999 Xiwang Road, Jiading District, Shanghai
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: The subjects should meet the following criteria: 1. Commitment to follow the research procedures and cooperate with the implementation of the whole process research. 2. Specified gender or age range. 3. According to the diagnosis, symptoms and signs of lung cancer or benign lung disease, or in general good health, can adhere to and cooperate with research intervention, such as chemotherapy. 4. Signed and dated informed consent.
Exclusion criteria
Exclusion criteria: Subjects who met any of the following criteria were excluded from this study: 1. Specific drugs that are not allowed are currently being used. 2. Equipped with a specific device (e.g. cardiac pacemaker). 3. In pregnancy or lactation. 4. New coronavirus infection or other febrile diseases occurred during the follow-up period. 5. Treatment with other trial drugs at a specific time. 6. There are specified diseases or conditions excluded from the study (physical or psychological, physical examination findings). 7. There were serious heart, lung, liver and kidney dysfunction and mental disorders. 8. In the past, we have received clinical therapeutic interventions related to lung cancer, such as surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy, etc. 9. Because of the sampling problem, it can not meet the requirements of the Research Institute for histopathological examination 10. There was a history of malignant tumor in recent 5 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CTC;CTC;Canceration;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactGu Zhidong
Ruijin Hospital North, Shanghai Jiaotong University, School of Medicine
Outcome results
None listed